EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms

E. Sanpaolo, M. Miroballo, S. Corbetta, C. Verdelli, F. Baorda, T. Balsamo, P. Graziano, F. P. Fabrizio, L. Cinque, A. Scillitani, L. A. Muscarella, Vito Guarnieri

Research output: Contribution to journalArticle

Abstract

Several studies reported somatic mutations of many genes (MEN1, CTNNB1, CDKIs and others) in parathyroid adenoma, although with different prevalence. Recently, activating mutations of the EZH2 and ZFX oncogenes were identified in benign parathyroid adenoma by whole exome sequencing. The same mutations had been found in blood and ovary malignant tumours. On one hand, this result raised the hypothesis that these oncogenes may play a role in the onset of parathyroid tumour, but it would also suggest they may be involved in malignant, rather benign, parathyroid neoplasm. Our aim was to verify the occurrence of selected mutations of the EZH2 and ZFX genes in an Italian cohort of 23 sporadic parathyroid carcinomas, 12 atypical and 45 typical adenomas. DNA was extracted from paraffin-embedded tissues, PCR amplified and directly sequenced. No mutations were detected in the coding sequence and boundaries of both genes in any of the samples. Two polymorphisms of the EZH2 gene were identified with different prevalence: the rs2072407 variant was present in the 30 % of the samples, in keeping with the overall frequency in larger populations, while the rs78589034 variant, located close to the 5′ end of the exon 16, was detected in only one proband with familial isolated hyperparathyroidism; we investigated the possible outcome on the splicing process. EZH2 and ZFX genes do not seem to have an impact on the onset of most parathyroid tumours, both benign and malignant, though further studies on larger cohorts of different ethnicity are needed.

Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalEndocrine
DOIs
Publication statusAccepted/In press - Feb 15 2016

Fingerprint

Parathyroid Neoplasms
Oncogenes
Mutation
Genes
Neoplasms
Exome
Multiple Endocrine Neoplasia Type 1
Adenoma
Paraffin
Ovary
Exons
Polymerase Chain Reaction
DNA
Population

Keywords

  • Atypical adenoma
  • EZH2
  • Parathyroid carcinoma
  • ZFX

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms. / Sanpaolo, E.; Miroballo, M.; Corbetta, S.; Verdelli, C.; Baorda, F.; Balsamo, T.; Graziano, P.; Fabrizio, F. P.; Cinque, L.; Scillitani, A.; Muscarella, L. A.; Guarnieri, Vito.

In: Endocrine, 15.02.2016, p. 1-5.

Research output: Contribution to journalArticle

Sanpaolo, E. ; Miroballo, M. ; Corbetta, S. ; Verdelli, C. ; Baorda, F. ; Balsamo, T. ; Graziano, P. ; Fabrizio, F. P. ; Cinque, L. ; Scillitani, A. ; Muscarella, L. A. ; Guarnieri, Vito. / EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms. In: Endocrine. 2016 ; pp. 1-5.
@article{954e94fad5ca47cc8c336a481e627f9d,
title = "EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms",
abstract = "Several studies reported somatic mutations of many genes (MEN1, CTNNB1, CDKIs and others) in parathyroid adenoma, although with different prevalence. Recently, activating mutations of the EZH2 and ZFX oncogenes were identified in benign parathyroid adenoma by whole exome sequencing. The same mutations had been found in blood and ovary malignant tumours. On one hand, this result raised the hypothesis that these oncogenes may play a role in the onset of parathyroid tumour, but it would also suggest they may be involved in malignant, rather benign, parathyroid neoplasm. Our aim was to verify the occurrence of selected mutations of the EZH2 and ZFX genes in an Italian cohort of 23 sporadic parathyroid carcinomas, 12 atypical and 45 typical adenomas. DNA was extracted from paraffin-embedded tissues, PCR amplified and directly sequenced. No mutations were detected in the coding sequence and boundaries of both genes in any of the samples. Two polymorphisms of the EZH2 gene were identified with different prevalence: the rs2072407 variant was present in the 30 {\%} of the samples, in keeping with the overall frequency in larger populations, while the rs78589034 variant, located close to the 5′ end of the exon 16, was detected in only one proband with familial isolated hyperparathyroidism; we investigated the possible outcome on the splicing process. EZH2 and ZFX genes do not seem to have an impact on the onset of most parathyroid tumours, both benign and malignant, though further studies on larger cohorts of different ethnicity are needed.",
keywords = "Atypical adenoma, EZH2, Parathyroid carcinoma, ZFX",
author = "E. Sanpaolo and M. Miroballo and S. Corbetta and C. Verdelli and F. Baorda and T. Balsamo and P. Graziano and Fabrizio, {F. P.} and L. Cinque and A. Scillitani and Muscarella, {L. A.} and Vito Guarnieri",
year = "2016",
month = "2",
day = "15",
doi = "10.1007/s12020-016-0892-y",
language = "English",
pages = "1--5",
journal = "Endocrine",
issn = "1355-008X",
publisher = "Humana Press Inc.",

}

TY - JOUR

T1 - EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms

AU - Sanpaolo, E.

AU - Miroballo, M.

AU - Corbetta, S.

AU - Verdelli, C.

AU - Baorda, F.

AU - Balsamo, T.

AU - Graziano, P.

AU - Fabrizio, F. P.

AU - Cinque, L.

AU - Scillitani, A.

AU - Muscarella, L. A.

AU - Guarnieri, Vito

PY - 2016/2/15

Y1 - 2016/2/15

N2 - Several studies reported somatic mutations of many genes (MEN1, CTNNB1, CDKIs and others) in parathyroid adenoma, although with different prevalence. Recently, activating mutations of the EZH2 and ZFX oncogenes were identified in benign parathyroid adenoma by whole exome sequencing. The same mutations had been found in blood and ovary malignant tumours. On one hand, this result raised the hypothesis that these oncogenes may play a role in the onset of parathyroid tumour, but it would also suggest they may be involved in malignant, rather benign, parathyroid neoplasm. Our aim was to verify the occurrence of selected mutations of the EZH2 and ZFX genes in an Italian cohort of 23 sporadic parathyroid carcinomas, 12 atypical and 45 typical adenomas. DNA was extracted from paraffin-embedded tissues, PCR amplified and directly sequenced. No mutations were detected in the coding sequence and boundaries of both genes in any of the samples. Two polymorphisms of the EZH2 gene were identified with different prevalence: the rs2072407 variant was present in the 30 % of the samples, in keeping with the overall frequency in larger populations, while the rs78589034 variant, located close to the 5′ end of the exon 16, was detected in only one proband with familial isolated hyperparathyroidism; we investigated the possible outcome on the splicing process. EZH2 and ZFX genes do not seem to have an impact on the onset of most parathyroid tumours, both benign and malignant, though further studies on larger cohorts of different ethnicity are needed.

AB - Several studies reported somatic mutations of many genes (MEN1, CTNNB1, CDKIs and others) in parathyroid adenoma, although with different prevalence. Recently, activating mutations of the EZH2 and ZFX oncogenes were identified in benign parathyroid adenoma by whole exome sequencing. The same mutations had been found in blood and ovary malignant tumours. On one hand, this result raised the hypothesis that these oncogenes may play a role in the onset of parathyroid tumour, but it would also suggest they may be involved in malignant, rather benign, parathyroid neoplasm. Our aim was to verify the occurrence of selected mutations of the EZH2 and ZFX genes in an Italian cohort of 23 sporadic parathyroid carcinomas, 12 atypical and 45 typical adenomas. DNA was extracted from paraffin-embedded tissues, PCR amplified and directly sequenced. No mutations were detected in the coding sequence and boundaries of both genes in any of the samples. Two polymorphisms of the EZH2 gene were identified with different prevalence: the rs2072407 variant was present in the 30 % of the samples, in keeping with the overall frequency in larger populations, while the rs78589034 variant, located close to the 5′ end of the exon 16, was detected in only one proband with familial isolated hyperparathyroidism; we investigated the possible outcome on the splicing process. EZH2 and ZFX genes do not seem to have an impact on the onset of most parathyroid tumours, both benign and malignant, though further studies on larger cohorts of different ethnicity are needed.

KW - Atypical adenoma

KW - EZH2

KW - Parathyroid carcinoma

KW - ZFX

UR - http://www.scopus.com/inward/record.url?scp=84957956226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957956226&partnerID=8YFLogxK

U2 - 10.1007/s12020-016-0892-y

DO - 10.1007/s12020-016-0892-y

M3 - Article

AN - SCOPUS:84957956226

SP - 1

EP - 5

JO - Endocrine

JF - Endocrine

SN - 1355-008X

ER -